ArticleEClinicalMedicine2023

Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial.

Stéphane Zuily et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.